Market Access & Patient Advocacy Subcommittee

Charter

The Market Access & Patient Advocacy Subcommittee strives to:

  • Educate the cell therapy industry on pre-commercialization reimbursement considerations.
  • Identify and recruit leaders in industry who have late-stage development products and have addressed regulatory and manufacturing hurdles.

Projects and Objectives

  • Describe reimbursement policies on a regional basis to include the UK, Australia and USA.
  • Organize an ISCT webinar on reimbursement considerations.



 

Committee Chair

Gerhard Bauer, PhD
Chair
UC Davis
Sacramento, CA, United States 

 

Committee Members

Miguel Forte, MD, PhD
Bone Therapeutics
Brussels, Belgium

Lynn Gallant
BlueRock Therapeutics
Cambridge, MA, United States

  
Stacy Herb, MPH, MBA
Celularity
Newark, NJ, United States
Chris McClain, PhD
Be The Match BioTherapies
Minneapolis, MN, United States
  
Siofradh McMahon, MSc
CCRM
Toronto, ON, Canada
Erika Siren, PhD
Takeda
Vancouver, CA, United States


 

© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy